233 related articles for article (PubMed ID: 34032966)
1. Knockdown of ANXA10 inhibits proliferation and promotes apoptosis of papillary thyroid carcinoma cells by down-regulating TSG101 thereby inactivating the MAPK/ERK signaling pathway.
Wei T; Zhu X
J Bioenerg Biomembr; 2021 Aug; 53(4):429-440. PubMed ID: 34032966
[TBL] [Abstract][Full Text] [Related]
2. Semaphorin 3D inhibits proliferation and migration of papillary thyroid carcinoma by regulating MAPK/ERK signaling pathway.
Hai R; You Q; Wu F; Qiu G; Yang Q; Shu L; Xie L; Zhou X
Mol Biol Rep; 2022 May; 49(5):3793-3802. PubMed ID: 35190928
[TBL] [Abstract][Full Text] [Related]
3. microRNA-124-3p inhibits tumourigenesis by targeting mitogen-activated protein kinase 4 in papillary thyroid carcinoma.
Sun Y; Zhang L; Zhang S
Cell Biochem Funct; 2020 Dec; 38(8):1017-1024. PubMed ID: 32495394
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of TSG101 by small interfering RNA inhibits the proliferation of breast cancer cells through the MAPK/ERK signal pathway.
Zhang Y; Song M; Cui ZS; Li CY; Xue XX; Yu M; Lu Y; Zhang SY; Wang EH; Wen YY
Histol Histopathol; 2011 Jan; 26(1):87-94. PubMed ID: 21117030
[TBL] [Abstract][Full Text] [Related]
5. DPP4 gene silencing inhibits proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through suppression of the MAPK pathway.
Hu X; Chen S; Xie C; Li Z; Wu Z; You Z
J Endocrinol Invest; 2021 Aug; 44(8):1609-1623. PubMed ID: 33387351
[TBL] [Abstract][Full Text] [Related]
6. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.
Huang F; Zhang Q; Chen W; Zhang H; Lu G; Chen J; Qiu C
J Cell Biochem; 2019 Jun; 120(6):10380-10390. PubMed ID: 30609134
[TBL] [Abstract][Full Text] [Related]
8. STAT1-induced upregulation of lncRNA LINP1 promotes cell proliferation and inhibits apoptosis via AMPK signaling pathway in papillary thyroid cancer.
Li HP; Yang TZ; Wei L; Ge YF; Meng QS
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8911-8917. PubMed ID: 32964981
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-486 inhibits cell proliferation, invasion and migration via down-regulating the TENM1 expressions and affecting ERK and Akt signaling pathways and epithelial-to-mesenchymal transition in papillary thyroid carcinoma.
Sun YH; Liu ZF; Yang BB; Yu B
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8429-8439. PubMed ID: 31646573
[TBL] [Abstract][Full Text] [Related]
10. Ropivacaine inhibits proliferation, invasion, migration and promotes apoptosis of papillary thyroid cancer cells via regulating ITGA2 expression.
Qin A; Liu Q; Wang J
Drug Dev Res; 2020 Sep; 81(6):700-707. PubMed ID: 32314406
[TBL] [Abstract][Full Text] [Related]
11. ciRS-7 Promotes the Proliferation and Migration of Papillary Thyroid Cancer by Negatively Regulating the miR-7/Epidermal Growth Factor Receptor Axis.
Han JY; Guo S; Wei N; Xue R; Li W; Dong G; Li J; Tian X; Chen C; Qiu S; Wang T; Xiao Q; Liu C; Xu J; Chen KS
Biomed Res Int; 2020; 2020():9875636. PubMed ID: 32685551
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of long noncoding RNA SLC26A4-AS1 inhibits the epithelial-mesenchymal transition via the MAPK pathway in papillary thyroid carcinoma.
Wang DP; Tang XZ; Liang QK; Zeng XJ; Yang JB; Xu J
J Cell Physiol; 2020 Mar; 235(3):2403-2413. PubMed ID: 31556116
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of annexin A10 in gastric cancer and its overexpression in tumor cell growth suppression.
Kim JK; Kim PJ; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Shan JM; Ping WY; Park WS; Lee JY; Nam SW
Oncol Rep; 2010 Sep; 24(3):607-12. PubMed ID: 20664964
[TBL] [Abstract][Full Text] [Related]
14. miRNA-21 promotes cell proliferation and invasion via VHL/PI3K/AKT in papillary thyroid carcinoma.
Zang C; Sun J; Liu W; Chu C; Jiang L; Ge R
Hum Cell; 2019 Oct; 32(4):428-436. PubMed ID: 31161410
[TBL] [Abstract][Full Text] [Related]
15. IL-34 is a potential biomarker for the treatment of papillary thyroid cancer.
Zhang P; Zhang H; Dong W; Wang Z; Qin Y; Wu C; Dong Q
J Clin Lab Anal; 2020 Aug; 34(8):e23335. PubMed ID: 32573824
[TBL] [Abstract][Full Text] [Related]
16. MiR-296-5p suppresses papillary thyroid carcinoma cell growth via targeting PLK1.
Zhou SL; Tang QL; Zhou SX; Ren RZ
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2084-2091. PubMed ID: 30915753
[TBL] [Abstract][Full Text] [Related]
17. Annexin A10 is a novel prognostic biomarker of papillary thyroid cancer.
Liu X; Yang M; Guo Y; Lu X
Ir J Med Sci; 2021 Feb; 190(1):59-65. PubMed ID: 32451762
[TBL] [Abstract][Full Text] [Related]
18. Yes-associated protein 1 promotes papillary thyroid cancer cell proliferation by activating the ERK/MAPK signaling pathway.
Liao T; Wen D; Ma B; Hu JQ; Qu N; Shi RL; Liu L; Guan Q; Li DS; Ji QH
Oncotarget; 2017 Feb; 8(7):11719-11728. PubMed ID: 28036290
[TBL] [Abstract][Full Text] [Related]
19. Suppression of long noncoding RNA LINC00324 restricts cell proliferation and invasion of papillary thyroid carcinoma through downregulation of TRIM29 via upregulating microRNA-195-5p.
Xu J; Li Z; Su Q; Zhao J; Ma J
Aging (Albany NY); 2020 Dec; 12(24):26000-26011. PubMed ID: 33318312
[TBL] [Abstract][Full Text] [Related]
20. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
Ma Y; Qin H; Cui Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]